Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications
Haptoglobin is a protein involved in protecting the body from the harmful effects of free hemoglobin. The haptoglobin gene exhibits a polymorphism, and the different genotypes do not have the same capacity to combat the free hemoglobin effects. The present study aimed at determining the polymorphic...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Advances in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2021/6939413 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832548821958131712 |
|---|---|
| author | Christian Bernard Kengne Fotsing Constant Anatole Pieme Prosper Cabral Biapa Nya Jean Paul Chedjou Samuel Ashusong Gisele Njindam Jocelyn Tony Nengom Georges Teto Carine Nguemeni Wilfred Fon Mbacham Donatien Gatsing |
| author_facet | Christian Bernard Kengne Fotsing Constant Anatole Pieme Prosper Cabral Biapa Nya Jean Paul Chedjou Samuel Ashusong Gisele Njindam Jocelyn Tony Nengom Georges Teto Carine Nguemeni Wilfred Fon Mbacham Donatien Gatsing |
| author_sort | Christian Bernard Kengne Fotsing |
| collection | DOAJ |
| description | Haptoglobin is a protein involved in protecting the body from the harmful effects of free hemoglobin. The haptoglobin gene exhibits a polymorphism, and the different genotypes do not have the same capacity to combat the free hemoglobin effects. The present study aimed at determining the polymorphic distribution of haptoglobin in sickle cell patients (SCPs) from West Cameroon and their impact on the hematological parameters, as well as clinical manifestations of the disease severity. Haptoglobin genotype of 102 SCPs (SS) and 115 healthy individuals (60 AA and 55 AS) was determined by allele-specific polymerase chain reaction, and the complete blood count was determined using the AutoAnalyser. Results showed that the genotype Hp2-2 was significantly (p < 0.05) represented in SS patients (54%) than in controls AA and AS (27% and 29%, respectively), while Hp2-1 was mostly found (p < 0.05) in AS (42%) and AA (38%), against 15% in SS. The allelic distribution in SS patients was Hp2: 0.613, Hp1S: 0.304, and Hp1F: 0.084. In AA and AS controls, the proportions of the Hp1 and Hp2 alleles were similar (around 0.5 each), with 0.282 for Hp1S and 0.218 for Hp1F in AS and 0.283 for Hp1S and 0.258 for Hp1F in AA. The distribution of the haptoglobin genotypes did not reveal any significant difference across hematological parameters and clinical manifestations of disease severity in SCP and controls. SCP with Hp1S-1F genotype presented the highest level of hemoglobin. Although Hp2-2 was more frequent in SS patients, it appeared not to be related to the hematological parameters and to the disease’s severity. Further investigations are necessary to explore the impact of Hp polymorphism such as antioxidant, lipid profile, and functionality of some tissues in SCP in Cameroon. |
| format | Article |
| id | doaj-art-6f9d0125ff794b5ab188d30c6d8602c7 |
| institution | Kabale University |
| issn | 1687-9104 1687-9112 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Advances in Hematology |
| spelling | doaj-art-6f9d0125ff794b5ab188d30c6d8602c72025-02-03T06:12:52ZengWileyAdvances in Hematology1687-91041687-91122021-01-01202110.1155/2021/69394136939413Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical ImplicationsChristian Bernard Kengne Fotsing0Constant Anatole Pieme1Prosper Cabral Biapa Nya2Jean Paul Chedjou3Samuel Ashusong4Gisele Njindam5Jocelyn Tony Nengom6Georges Teto7Carine Nguemeni8Wilfred Fon Mbacham9Donatien Gatsing10Research Unit of Microbiology and Antimicrobial Substances, Department of Biochemistry, Faculty of Science, University of Dschang, P O. Box 67, Dschang, CameroonLaboratory of Biochemistry, Department of Biochemistry and Physiological Sciences, Faculty of Medicine and Biomedical Sciences, University of Yaounde I, P O. Box, Yaounde 1364, CameroonResearch Unit of Biochemistry of Medicinal Plants, Food Sciences and Nutrition, Department of Biochemistry, Faculty of Science, University of Dschang, P O. Box 67, Dschang, CameroonLaboratory for Public Health Research Biotechnology, Department of Biochemistry, University of Yaounde I, Yaounde, CameroonBafoussam Regional Hospital, P O. Box 980, Bafoussam, CameroonBafoussam Regional Hospital, P O. Box 980, Bafoussam, CameroonBafoussam Regional Hospital, P O. Box 980, Bafoussam, CameroonCentre International de Recherche Chantal Biya, Yaounde, CameroonDepartment of Neurology, University Hospital of Würzburg, Würzburg, GermanyLaboratory for Public Health Research Biotechnology, Department of Biochemistry, University of Yaounde I, Yaounde, CameroonResearch Unit of Microbiology and Antimicrobial Substances, Department of Biochemistry, Faculty of Science, University of Dschang, P O. Box 67, Dschang, CameroonHaptoglobin is a protein involved in protecting the body from the harmful effects of free hemoglobin. The haptoglobin gene exhibits a polymorphism, and the different genotypes do not have the same capacity to combat the free hemoglobin effects. The present study aimed at determining the polymorphic distribution of haptoglobin in sickle cell patients (SCPs) from West Cameroon and their impact on the hematological parameters, as well as clinical manifestations of the disease severity. Haptoglobin genotype of 102 SCPs (SS) and 115 healthy individuals (60 AA and 55 AS) was determined by allele-specific polymerase chain reaction, and the complete blood count was determined using the AutoAnalyser. Results showed that the genotype Hp2-2 was significantly (p < 0.05) represented in SS patients (54%) than in controls AA and AS (27% and 29%, respectively), while Hp2-1 was mostly found (p < 0.05) in AS (42%) and AA (38%), against 15% in SS. The allelic distribution in SS patients was Hp2: 0.613, Hp1S: 0.304, and Hp1F: 0.084. In AA and AS controls, the proportions of the Hp1 and Hp2 alleles were similar (around 0.5 each), with 0.282 for Hp1S and 0.218 for Hp1F in AS and 0.283 for Hp1S and 0.258 for Hp1F in AA. The distribution of the haptoglobin genotypes did not reveal any significant difference across hematological parameters and clinical manifestations of disease severity in SCP and controls. SCP with Hp1S-1F genotype presented the highest level of hemoglobin. Although Hp2-2 was more frequent in SS patients, it appeared not to be related to the hematological parameters and to the disease’s severity. Further investigations are necessary to explore the impact of Hp polymorphism such as antioxidant, lipid profile, and functionality of some tissues in SCP in Cameroon.http://dx.doi.org/10.1155/2021/6939413 |
| spellingShingle | Christian Bernard Kengne Fotsing Constant Anatole Pieme Prosper Cabral Biapa Nya Jean Paul Chedjou Samuel Ashusong Gisele Njindam Jocelyn Tony Nengom Georges Teto Carine Nguemeni Wilfred Fon Mbacham Donatien Gatsing Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications Advances in Hematology |
| title | Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications |
| title_full | Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications |
| title_fullStr | Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications |
| title_full_unstemmed | Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications |
| title_short | Haptoglobin Gene Polymorphism among Sickle Cell Patients in West Cameroon: Hematological and Clinical Implications |
| title_sort | haptoglobin gene polymorphism among sickle cell patients in west cameroon hematological and clinical implications |
| url | http://dx.doi.org/10.1155/2021/6939413 |
| work_keys_str_mv | AT christianbernardkengnefotsing haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT constantanatolepieme haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT prospercabralbiapanya haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT jeanpaulchedjou haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT samuelashusong haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT giselenjindam haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT jocelyntonynengom haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT georgesteto haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT carinenguemeni haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT wilfredfonmbacham haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications AT donatiengatsing haptoglobingenepolymorphismamongsicklecellpatientsinwestcameroonhematologicalandclinicalimplications |